Should health insurers target prevention of cardiovascular disease? A cost-effectiveness analysis of an individualised programme in Germany based on routine data.
about
Pharmacoeconomics of PCSK9 inhibitors in 103 hypercholesterolemic patients referred for diagnosis and treatment to a cholesterol treatment center.A systematic review of economic evaluations of screening programmes for cardiometabolic diseases.Health economic evaluations based on routine data in Germany: a systematic review.
P2860
Should health insurers target prevention of cardiovascular disease? A cost-effectiveness analysis of an individualised programme in Germany based on routine data.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Should health insurers target ...... Germany based on routine data.
@ast
Should health insurers target ...... Germany based on routine data.
@en
type
label
Should health insurers target ...... Germany based on routine data.
@ast
Should health insurers target ...... Germany based on routine data.
@en
prefLabel
Should health insurers target ...... Germany based on routine data.
@ast
Should health insurers target ...... Germany based on routine data.
@en
P2093
P2860
P356
P1476
Should health insurers target ...... Germany based on routine data.
@en
P2093
Christian Becker
Johannes Brachmann
Kurt Bestehorn
Majed Aljutaili
Michael Block
Reiner Leidl
Rolf Holle
Sabine Witt
Sigmund Silber
P2860
P2888
P356
10.1186/1472-6963-14-263
P577
2014-06-17T00:00:00Z
P5875
P6179
1041121780